We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Information about the risks of taking valproate medicines during pregnancy.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Information for patients who have been prescribed Lagevrio (molnupiravir), the COVID-19 oral antiviral medication.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Check the tariff classification for flavour pods.
Strandhaven Limited T/A Somex Pharma has informed the MHRA that the pack size on some cartons of the batch in this notification state 8 tablets instead of 4 tablets.
The management, surveillance and epidemiology of carbapenem resistance.
Details of certificates issued under the Special Import System for the top ten imported veterinary medicines 1 April - 30 June 2023.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Check the tariff classification for peptide nisin standardised with sodium chloride
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Quadrant Pharmaceuticals Ltd has informed the MHRA of an error with the Patient Information Leaflets (PILs) in the listed batches of Cozaar 100mg film-coated tablets.
Information for British nationals who are victims of rape or sexual assault in the Cook Islands.
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
Information for patients who have been prescribed Paxlovid (nirmatrelvir 150mg and ritonavir 100mg) film-coated tablets COVID-19 antiviral medication.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.